TTRX (Turn Therapeutics Inc. Common Stock) Stock Analysis - Financials

Turn Therapeutics Inc. Common Stock (TTRX) is a publicly traded the market company. As of May 21, 2026, TTRX trades at $4.48 with a market cap of $145.96M and a P/E ratio of -40.28. TTRX moved +0.00% today. Year to date, TTRX is +0.63%; over the trailing twelve months it is flat. Its 52-week range spans $2.57 to $26.50. Rallies surfaces TTRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are TTRX's key financials?

TTRX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. TTRX recently traded at $4.48. Market cap is $145.96M. P/E ratio is -40.28. Revenue is $0.

TTRX Key Metrics

Key financial metrics for TTRX
MetricValue
Price$4.48
Market Cap$145.96M
P/E Ratio-40.28
EPS$-0.12
Dividend Yield0.00%
52-Week High$26.50
52-Week Low$2.57
Volume6
Avg Volume0
Revenue (TTM)$0
Net Income$-3.19M
Gross Margin0.00%

TTRX Annual Financials

YearRevenueNet IncomeEPS
2025$0$-3.19M$-0.12

Latest TTRX News

Recent TTRX Insider Trades

  • Chaudhary Zuraiz bought 2.50K (~$8.75K) on Dec 12, 2025.
  • GOLDEN ARTHUR F bought 9.87K (~$33.95K) on Nov 24, 2025.
  • GOLDEN ARTHUR F bought 20.53K (~$58.93K) on Nov 21, 2025.

TTRX Analyst Consensus

TTRX analyst coverage data. Average price target: $0.00.

Common questions about TTRX

What are TTRX's key financials?
TTRX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. TTRX recently traded at $4.48. Market cap is $145.96M. P/E ratio is -40.28. Revenue is $0.
Is TTRX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for TTRX. It does not provide personalized investment advice.
TTRX

TTRX